QIAGEN acquisition of Parse Biosciences, Inc.
Acquisition04/11/2025
QIAGEN announced its agreement to acquire Parse Biosciences, Inc. on November 4, 2025. The 2025 annual report confirms completion on December 2, 2025 and acquisition of [figure hidden] of its shares. Parse supplies instrument-free single-cell research products. No individual selling investor proceeds are established.
Type
Acquisition
Announced
04/11/2025
Amount
Financial data requires access
Reported parties
QIAGEN N.V.; Parse Biosciences, Inc.